Therapie

Article	Citations
Uses of pharmacovigilance databases: An overview	95
“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers	87
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection	70
Safety data and withdrawal of hepatotoxic drugs	54
Addictovigilance contribution during COVID-19 epidemic and lockdown in France	51
Pharmacovigilance and drug safety: Fair prescribing and clinical research	49
Polypharmacy: A general review of definitions, descriptions and determinants	37
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)	33
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence	33
Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations	33
Efficacy of COVID-19 vaccines: From clinical trials to real life	30
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres	25
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge	23
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy	22
Diabetes and COVID-19	21
Prolonged-release buprenorphine formulations: Perspectives for clinical practice	20
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France	20
Chloroquine and hydroxychloroquine during pregnancy: What do we know?	19
Self-medication practices and their characteristics among French university students	17
Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19	16
COVID-19 and NSAIDs: Primum non nocere	14
Genital tract and reproductive characteristics in daughters of women and men prenatally exposed to diethylstilbestrol (DES)	13
COVID-19 vaccines: A perspective from social pharmacology	12
Thrombotic events after AstraZeneca vaccine: What if it was related to dysfunctional immune response?	11
Innovative approaches in CNS drug discovery	11

Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials	10
Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review	10
Epidemiology and economic burden of “serious” adverse drug reactions: Real-world evidence research based on pharmacovigilance data	10
Warning on increased serious health complications related to non-medical use of nitrous oxide	9
Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature	9
Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy. An in vitro assessment	9
Efficacy of metformin on glycemic control and weight in drug-naive type 2 diabetes mellitus patients: A systematic review and meta-analysis of placebo-controlled randomized trials	9
Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database	9
NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection	9
Is the drug a scientific, social or political object?	8
Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19	8
A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy	8
Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021	8
Vaccines and Bell's palsy: A narrative review	8
Place of patient-reported outcomes & experiences measurements (PROMS/PREMS) in the assessment and pricing of Health technologies in France	8
Incretin-based drugs and intestinal obstruction: A pharmacovigilance study	8
La pharmacogénétique au service du soin en France : une discipline qui évolue !	8
Comparative study of the adverse event profile of hydroxychloroquine before and during the Sars-CoV2 pandemic	7
Calcium channel blocker exposure and psoriasis risk: Pharmacovigilance investigation and literature data	7
Consommation de substances chez les jeunes : du médicament aux substances illicites	7
Drugs acting on renin angiotensin system and use in ill patients with COVID-19	7
Drug-induced meningitis: A review of the literature and comparison with an historical cohort of viral meningitis cases	7
Skin cancers under Janus kinase inhibitors: A World Health Organization drug safety database analysis	7
Doping with aromatase inhibitors and oestrogen receptor modulators in steroid users: Analysis of a forum to identify dosages, durations and adverse drug reactions	7
Le mésusage du fentanyl en France : 2010 à 2015	7
Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database	6
COVID-19 vaccines and pregnancy: What do we know?	6
Penetration rate of anti-TNF biosimilars and savings at 5 years after their introduction in French hospitals	6
Atteintes musculaires et levure de riz rouge : analyse des données de la base nationale de pharmacovigilance et revue de la littérature	6
Adverse drug reactions of hydroxychloroquine: Analysis of French pre-pandemic SARS-CoV2 pharmacovigilance data	6
Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol	6
Global research output in ‘pharmacovigilance’ during 2010–2020	6
A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19	6
Synthèse des recommandations de l’International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) sur le suivi thérapeutique pharmacologique du tacrolimus	5
Les politiques de partage de données des financeurs d’essais cliniques en France	5
Central diabetes insipidus revealing a hypophysitis induced by SARS-CoV-2 vaccine	5
Analyse des seringues usagées : un reflet de la consommation de substances psychoactives par les usagers de drogues par voie intraveineuse ?	5
Are β-lactam concentrations adequate in severe sepsis and septic shock in children?	5
Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic	5
Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022	5
Profils d’effets indésirables sous abiratérone et enzalutamide : analyse descriptive des données de la base nationale de pharmacovigilance	5
Connaissances et attitudes des médecins généralistes à l’égard des effets indésirables des inhibiteurs de la pompe à protons	5
The need to shed light on potential insidious SARS-CoV-2 post-vaccination pituitary lesions	5
Éruption eczématiforme après le vaccin par Pfizer-BioNTech COVID-19	5
The French pharmacovigilance surveys: A French distinctiveness, a real input	5
Platform trials	5
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects	4
Les médicaments potentiellement inappropriés : adaptation de la liste EU(7)PIM à la pratique médicale française	4
Quality of evidence of the efficacy of therapeutic interventions on patient-important outcomes in Cochrane's systematic reviews’ abstracts: A survey	4
Pharmacologie du cannabidiol : points de vigilance, conséquences et risques chez l’homme	4

Adherence after treatment switch from a multiple tablet antiretroviral regimen to a single tablet antiretroviral regimen	4
The drugs that mostly frequently induce gynecomastia: A national case – noncase study	4
Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance study	4
Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice	4
Drug consumption during prolonged lockdown due to Covid-19 as observed in French addiction center	4
Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series	4
Is caspofungin efficient to treat invasive candidiasis requiring continuous veno-venous hemofiltration? A case report	4
Statin-associated myasthenia: A case report and literature review	4
Chronic spontaneous urticaria following vaccination against SARS-CoV-2	4
Association of UGT2B7 and CaMK4 with response of valproic acid in Chinese children with epilepsy	4
Towards personalized pharmacology: Antipsychotics and schizophrenia	3
DPP-4 inhibitors and severe course of illness in patients with COVID-19	3
Meningiomas after cyproterone acetate exposure: Case reports in twin sisters	3
An atypical Ramsey Hunt syndrome after covid 19 immunization	3
DRESS syndrome with cholecystitis in a child: A case report and literature review	3
Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses’ infections	3
Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey	3
A historical cohort study to investigation of statins safety in COVID-19 hospitalized patients	3
Use of triptans during pregnancy? With caution!	3
Bacterial infections in people who inject psychoactive substances: An observational study in a French university hospital	3
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective	3
Pharmacokinetics of ceftolozane/tazobactam continuous infusion on renal replacement therapy: A pediatric case report	3
A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)	3
Suivi thérapeutique pharmacologique de la clozapine	3
Interactions médicamenteuses avec la colchicine, les contre-indications sont-elles bien respectées ? Étude descriptive des prescriptions en Bretagne à partir des données de l’Assurance maladie	3
Relapsing generalized bullous fixed drug eruption: A severe and avoidable cutaneous drug reaction. Three case reports	3
Refractory non-variceal upper gastrointestinal bleeding in a liver-transplant patient: Everolimus withdrawal should be considered	3
Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®	3
Green tea and hepatoxicity: Two case reports	3
Prescription errors by emergency physicians for inpatients are associated with emergency department length of stay	3
Adverse drug reactions in pregnant women: Do they differ from those in non-pregnant women of childbearing age?	3
The “old” cytotoxic drugs, the basis of anti-cancer treatments	3
Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic	3
Non-medical use of baclofen: A case series and review of the literature	3
Suivi thérapeutique pharmacologique de l’olanzapine	3
Cluster headache after COVID-19 vaccination with Comirnaty: A signal in pharmacovigilance database	3
Évaluation du potentiel d’abus et de dépendance de la quétiapine (Xeroquel®)	3
Daily practices regarding safety monitoring of low-dose methotrexate and comparison to guidelines: A population-based cohort study	3
Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives	3
Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic	3
Sex differences: From preclinical pharmacology to clinical pharmacology	3
Pharmacotherapy of substance use disorders in the neuroscience-based nomenclature (NbN)	3
Cinderella side effect: Intravenous corticosteroid-induced bradycardia	3
Enhancing the role played by clinical pharmacists in psychiatric settings to better integrate clinical psychopharmacology into the decision-making process	3
Urticaire sévère avec récidive compliquée d’angiœdème sous sécukinumab : à propos d’un cas	3
Consommer du CBD ou conduire, faut-il choisir ?	3
Minors and young adult's hospitalizations after “chimique” consumption in Mayotte Island: Which substances are involved?	3
Severe bone pain with teriflunomide: Five case reports and review of the French pharmacovigilance database	3
Les solutions numériques en santé, quelles valeurs apportées, quels mécanismes de financement et quelles évaluations ?	3
Androgens, QT, sex and ventricular repolarization–a double-edged sword: A case series	3
Déclaration des erreurs médicamenteuses dans les recherches portant sur le médicament : place du pharmacien des essais cliniques ?	3
Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)	3
Raising public awareness about the misuse of predatory journals: One year after the “hydroxychloroquine and push-scooters accidents” hoax	3
Immunotherapies in acute leukemia	3
Trente ans d’abus de néfopam en France	3
Pharmaciens d’officine, étudiants en pharmacie et demandes de médicaments à base de codéine : étude observationnelle	3
Leukocytoclastic vasculitis mimicking photosensitivity induced by thiamazole	2
Initial data on the safety of metopimazine during pregnancy and the risk of major birth defects and pregnancy loss – An observational study using the EFEMERIS database	2
Pulmonary hemorrhage in a neonate born to a woman with cystic fibrosis treated with targeted cystic fibrosis transmembrane conductance regulator modulator elexacaftor–tezacaftor–ivacaftor during pregn	2
A case of iatrogenic vitamin D toxicity revealed by drug reconciliation	2
Bismuth encephalopathy and mineral waters: a new hypothesis on bismuth absorption	2
Impact of diabetes mellitus on rifampicin's plasma concentration and bioavailability in patients with tuberculosis: A systematic review and meta-analysis study	2
Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in France	2
Modifications pharmacocinétiques liées à une infection aiguë. Exemples issus de la pandémie de SARS-CoV-2	2
Poids atropinique et médicaments anticholinergiques : intérêt et application en pratique clinique chez la personne âgée	2
Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!	2
Référentiel ECRIN pour la conformité aux bonnes pratiques de gestion des données des essais cliniques multinationaux	2
Évolution des comportements de consommation de produits psychoactifs illicites ou détournés de leur usage médicamenteux chez les femmes enceintes en France : analyse des données OPPIDUM de 2005 à 2018	2
Spiderweb-like pattern: A novel dermoscopic feature in photo-onycholysis induced by doxycycline?	2
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France	2
Delayed thrombocytopenia following administration of abciximab: Pharmacovigilance survey and literature review	2
Myocardial infarction in relation to colchicine poisoning: A precipitating cause of refractory toxic cardiogenic shock	2
Hypophosphatémie et fer injectable : à propos d’un cas et revue de la littérature	2
Usages de substances de synthèse en France et en Europe	2
Balneotherapy in spondyloarthropathy: A systematic review	2
Utilisation et gestion des inhibiteurs de la pompe à protons : une étude observationnelle	2
Complications infectieuses liées à l’utilisation du propofol : une nouvelle série de cas et revue de la littérature	2
Letrozole induced visual hallucination	2
Un tour d’horizon du développement de biomarqueurs pour les anticorps PD-1 et PD-L1 en cancérologie	2
The discovery of hypoglycaemic sulphonamides – Montpellier, 1942	2

Acute myocarditis during carboplatin and pemetrexed chemotherapy for lung adenocarcinoma	2
Buprénorphine d’action prolongée : quelles perspectives pour la pratique clinique ?	2
Imagerie TEP pour l’étude des répercussions fonctionnelles de la P-glycoprotéine en neuropharmacocinétique	2
Interaction entre amoxicilline/acide clavulanique et fluindione : à propos de deux cas	2
Un exemple de réorganisation dans le fonctionnement d’un Centre d’investigations cliniques en période de confinement national suite à la pandémie COVID-19	2
Health crisis: What opportunities for clinical drug research?	2
Pharmacokinetics and therapeutic drug monitoring of anticancer protein/kinase inhibitors	2
Ambulatory drug changes in the elderly after hospital discharge: A cohort study	2
No arguments for extra risk from ibuprofen in SARS-COV2 infection	2
Drug-induced cardiac toxicity and adverse drug reactions, a narrative review	2
Project rebuild the evidence base (REB): A method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients	2
Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study	2
Severe serotonin syndrome caused by an interaction between an antidepressant and a cough syrup	2
Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted	2
Étude observationnelle des déclarations de liens d’intérêts au Congrès de la médecine générale France et liens d’intérêts des médecins intervenants	2
Pourquoi et comment améliorer l’information des patients et de leurs aidants au bon usage de leurs dispositifs médicaux tout au long du parcours de soin ?	2
Hospitalisations après consommation de substances psychoactives pendant la pandémie de COVID-19	2
Adverse drug reaction monitoring: Doing it the French way – Act II	2
Efficacy and safety of neural stem cell therapy for spinal cord injury: A systematic literature review	2
The 2019 Global Initiative for Asthma report: Evidence-based or evidence-biased medicine?	2
General practitioners’ compliance with benzodiazepine discontinuation guidelines in patients treated with long-term lorazepam: A case-vignette cross-sectional survey	2
Les essais plateformes	2
Case report: Confirming a diagnosis of severe olmesartan-associated enteropathy	2
Syndrome coronarien aigu associé au dronabinol	2
Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic	2
Contributions of animal models of cognitive disorders to neuropsychopharmacology	2
Olmesartan-associated enteropathy: Belgian survey	2
Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology	2
Hypoglycémie sévère et arrêt cardiorespiratoire attribués au tramadol – à propos d’un cas	2